Calcium channel binding characteristics in the human heart

Area of Science:

• Cardiology
• Pharmacology
• Molecular Biology

Background:

• Calcium channels are crucial for cardiac function.
• Understanding their distribution and properties in human hearts is vital for therapeutic development.
• Previous studies often relied on animal models or indirect measures.

Purpose of the Study:

• To characterize the number, affinity, pharmacologic specificity, and regional distribution of calcium channel binding sites in human hearts.
• To investigate the feasibility of directly studying cardiac calcium channels in human tissue.
• To compare binding site characteristics in healthy hearts versus those with specific cardiac conditions.

Main Methods:

• Radioligand binding assays using [3H]nitrendipine.
• Scatchard analysis of saturation data from autopsy and surgical human heart specimens.
• Ligand competition experiments to assess pharmacologic specificity.
• Comparison of binding parameters in healthy, postmortem, and hypertrophic cardiomyopathy samples.

Main Results:

• Homogeneous distribution of high-affinity calcium channel binding sites (low KD, nanomolar range) across different human heart regions (atrium, ventricle, septum).
• Pharmacologic specificity confirmed with known calcium channel blockers (nifedipine, nitrendipine, verapamil) and diltiazem.
• Similar binding characteristics observed in fresh and up to 18-hour postmortem hamster hearts.
• Significantly increased binding capacity (Bmax) in a hypertrophic cardiomyopathy specimen compared to healthy controls.

Conclusions:

• Direct characterization of calcium channel binding sites in human hearts is feasible using radioligand assays.
• The study provides quantitative data on the distribution and affinity of these sites in healthy human myocardium.
• Findings suggest potential alterations in calcium channel binding in specific cardiac pathologies like hypertrophic cardiomyopathy, warranting further investigation.